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Leishmania 
infantum and 
Human Visceral 
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To the Editor: In Argentina, 
14 autochthonous human cases of 
visceral leishmaniasis (VL) were 
reported during 1925–1989. These 
cases occurred in different localities 
in Salta, Jujuy, Santiago del Estero, 
and Chaco Provinces of northwestern 
Argentina (online Appendix Figure, 
wwwnc.cdc.gov/EID/article/18/2/11-
0924-FA1.htm), where cutaneous 
leishmaniasis (CL) caused principally 
by Leishmania (Viannia) braziliensis 
is endemic.
It had been postulated that 
scattered/sporadic VL cases could 
be caused by visceralization of 
dermatrophic Leishmania spp. because 
of 1) absence of already recognized L. 
(Leishmania) infantum vector species; 
2) geographic overlap with the region 
where CL is endemic; 3) simultaneous 
symptoms of CL; or 4) lack of 
detailed parasitic characterization 
at the molecular level for cases of 
suspected VL (1). However, during 
recent decades, urban outbreaks of 
VL have spread to southern regions of 
South America (Mato Grosso do Sul, 
Brazil, and Asunción, Paraguay) near 
the northern border with Argentina.
In May 2006, an autochthonous 
human case of VL was reported in 
Posadas (northeastern Argentina); it 
was associated with the canine visceral 
form of the disease. In addition, the 
presence of Lutzomyia longipalpis 
sandﬂ   ies was also reported (2). 
Currently, 58 human VL cases have 
been reported in Posadas (3), and 
>7,000 infected dogs, Lu. longipalpis 
sandﬂ   ies, and canine VL have been 
found 350 km south of Posadas (4).
During 2007–2008, new VL cases 
in 4 children and 7 dogs were reported 
clustering in time and space in La 
Banda-Santiago del Estero in the dry 
Chaco region of Argentina. This focus 
showed a different pattern from that 
found in the only urban outbreak of 
VL reported (nearly the same number 
of cases in humans and dogs, and the 
suspected vector was Lu. migonei 
sandﬂ   ies instead of Lu. longipalpis 
sandﬂ  ies) (5).
We report a case of autochthonous 
human VL in Salta Argentina that 
was caused by L. (L.) infantum. 
This parasite was characterized by 
cytochrome b (cytb) gene sequencing. 
Sequencing of this gene has been 
validated for precise characterization 
of Leishmania spp. (6,7).
On September 9, 2009, a 44-year-
old man from Salta, Argentina (online 
Appendix Figure), was admitted to the 
Infectious Disease Service at Hospital 
Señor del Milagro in Salta. The patient 
had fever, weight loss, dyspepsia, and 
splenomegaly that evolved over 3 
weeks. Physical examination showed 
cutaneous and mucosal paleness. His 
general condition was feverish and 
rapidly deteriorating.
Laboratory tests at the time 
of  ﬁ   nal diagnosis showed anemia, 
leukocytopenia, thrombocytopenia, 
and increased levels of lactate 
dehydrogenase. Results of urinalysis 
and coproculture were negative for 
parasites. Electrophoresis of serum 
proteins showed increased levels of 
gamma globulins. The differential 
diagnosis was negative for malaria, 
mycosis, autoimmune hepatitis, and 
lymphoma. A bone marrow smear 
showed abundant amastigotes by 
Giemsa staining (Figure, panel A). 
The patient was treated with liposomal 
amphotericin B, 3 mg/day for 7 days, 
and recovered (8).
After a comprehensive interview, 
we veriﬁ  ed that this patient had not 
been in the VL-endemic area in 
Argentina. However, he had worked 
(deforestation activities) during 
January–February 2009 on a farm in 
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Figure. Case of autochthonous human visceral leishmaniasis in a 44-year-old man, 
identiﬁ   ed by parasitologic diagnosis and molecular detection of the causative species, 
Salta, Argentina. A) Leishmania amastigotes in a bone marrow smear. N, nucleus; K, 
kinetoplast; C, cytoplasm (Giemsa stained, original magniﬁ  cation ×1,000). B) Ampliﬁ  cation 
by nested PCR of cytochrome b gene of Leishmania infantum. Arrow indicates ampliﬁ  ed 
fragment of ≈850 bp. Lane B, blank control; lanes 1 and 2, patient bone marrow aspirate 
samples; lanes 3–6, samples from Leishmaniasis spp.–negative persons; lane P, positive 
control; lane N, negative control; lane M, 100-bp molecular mass marker.LETTERS
Finca Las Maravillas (22º3′29.30″S, 
63º14′28.17″W), where he had been 
bitten by phlebotomines and acquired 
the disease. This farm was situated in 
the dry Chaco region near the border 
with Bolivia and Paraguay (zones 
with VL) (9), a region with intensive 
deforestation and agricultural 
activities.
For species identiﬁ  cation,  DNA 
was extracted from a bone marrow 
aspirate and peripheral blood. 
We ampliﬁ   ed by nested PCR and 
sequenced the cytb gene (Figure, panel 
B) (6). The aligned 817-bp sequence 
obtained showed 100% homology 
with the cytb  gene of the MHOM/
TN/80/IPT1  L.  (L.)  infantum World 
Health Organization reference strain 
(Tunisian strain) and 99.3% homology 
with the MHOM/BR/74/PP75 L. (L.) 
chagasi strain (Brazilian strain) (7).
L. (L.) infantum was identiﬁ  ed as 
the causative agent of this VL case in 
Salta, Argentina, where VL cases had 
not been seen for 50 years. Our ﬁ  ndings 
indicate that this case was not caused 
by visceralization or a dermatropic 
Leishmania spp. We suggest that the 
scattered pattern of VL incidence in 
the dry Chaco region is caused by an 
enzootic cycle with accidental human 
transmission (5).
There are no reports of Lu. 
longipalpis sandﬂ   ies in the study 
area or surrounding areas (10). 
Nevertheless, studies on natural 
infections of vector sandﬂ  ies  and 
reservoir-host animals (especially 
dogs) are needed. Therefore, the 
search for naturally infected sandﬂ  ies 
and reservoirs of this infection should 
be intensiﬁ  ed. Epidemiologic surveys 
of dogs are needed to identify spread 
of VL foci in areas of deforestation. 
Deforestation could alter vector and 
reservoir range and parasite density in 
the enzootic cycle and increase human 
exposure to infected vectors.
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